Literature DB >> 26070875

Oestrogen replacement in postmenopausal women.

Jenifer Sassarini1, Mary Ann Lumsden1.   

Abstract

Menopausal symptoms can disrupt a woman's personal and social life. Vasomotor symptoms (hot flushes and night sweats) are the most common symptoms and can be treated very effectively with oestrogen-based hormone therapy. The decision to use oestrogen (often simply termed hormone therapy or hormone replacement therapy or HT) therapy involves balancing the potential benefits against the potential risks. Most agree that short-term oestrogen therapy, using the lowest effective dose, is a reasonable option for recently menopausal women with moderate-to-severe symptoms who are in good cardiovascular health (Martin and Manson. 2008. J. Clin. Endocrinol. Metab. 93, 4567-75). Whilst effective and safe in most instances, HT is not suitable for all women or for all menopause-related symptoms when alternatives are available. The role of HRT in chronic disease prevention is also discussed.
© The Author 2015. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  menopause; oestrogen replacement therapy; older people

Mesh:

Substances:

Year:  2015        PMID: 26070875     DOI: 10.1093/ageing/afv069

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  8 in total

1.  Perinatal Exposure to Bisphenol A or Diethylstilbestrol Increases the Susceptibility to Develop Mammary Gland Lesions After Estrogen Replacement Therapy in Middle-Aged Rats.

Authors:  Ayelen L Gomez; Melisa B Delconte; Gabriela A Altamirano; Lucia Vigezzi; Veronica L Bosquiazzo; Luís F Barbisan; Jorge G Ramos; Enrique H Luque; Mónica Muñoz-de-Toro; Laura Kass
Journal:  Horm Cancer       Date:  2017-01-11       Impact factor: 3.869

2.  Estrogen receptor subtype ratio change protects against podocyte damage.

Authors:  Paola Catanuto; Xiaomei Xia; Simone Pereira-Simon; Sharon Elliot
Journal:  Curr Trends Endocinol       Date:  2017

Review 3.  Estrogens and Androgens in Skeletal Physiology and Pathophysiology.

Authors:  Maria Almeida; Michaël R Laurent; Vanessa Dubois; Frank Claessens; Charles A O'Brien; Roger Bouillon; Dirk Vanderschueren; Stavros C Manolagas
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

4.  Soy Isoflavone Protects Myocardial Ischemia/Reperfusion Injury through Increasing Endothelial Nitric Oxide Synthase and Decreasing Oxidative Stress in Ovariectomized Rats.

Authors:  Yan Tang; Shuangyue Li; Ping Zhang; Jinbiao Zhu; Guoliang Meng; Liping Xie; Ying Yu; Yong Ji; Yi Han
Journal:  Oxid Med Cell Longev       Date:  2016-02-01       Impact factor: 6.543

5.  Resveratrol promotes osteoblastic differentiation in a rat model of postmenopausal osteoporosis by regulating autophagy.

Authors:  Wei Wang; Li-Mei Zhang; Chang Guo; Jian-Feng Han
Journal:  Nutr Metab (Lond)       Date:  2020-04-16       Impact factor: 4.169

6.  Effect of Interaction between 17β-Estradiol, 2-Methoxyestradiol and 16α-Hydroxyestrone with Chromium (VI) on Ovary Cancer Line SKOV-3: Preliminary Study.

Authors:  Ewa Sawicka; Jolanta Saczko; Joanna Roik; Julita Kulbacka; Agnieszka Piwowar
Journal:  Molecules       Date:  2020-11-09       Impact factor: 4.411

7.  17β-Estradiol sensitizes ovarian surface epithelium to transformation by suppressing Disabled-2 expression.

Authors:  Nhung H Vuong; Omar Salah Salah; Barbara C Vanderhyden
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

8.  Estrogen stimulates SREBP2 expression in hepatic cell lines via an estrogen response element in the SREBP2 promoter.

Authors:  Ye Meng; Lu Zong
Journal:  Cell Mol Biol Lett       Date:  2019-12-03       Impact factor: 5.787

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.